Peripheral Blood Stem Cell TransplantationStem CellsHematopoietic Stem Cell TransplantationAntineoplastic Combined Chemotherapy ProtocolsTransplantation, AutologousHematopoietic Stem Cell MobilizationHematopoietic Stem CellsGranulocyte Colony-Stimulating FactorStem Cell TransplantationLeukapheresisCord Blood Stem Cell TransplantationTransplantation, HomologousCombined Modality TherapyAntigens, CD34Blood Component RemovalCyclophosphamideEmbryonic Stem CellsChemotherapy, AdjuvantTransplantation ConditioningAdult Stem CellsMelphalanHematologic NeoplasmsTreatment OutcomeGraft vs Host DiseasePluripotent Stem CellsBone Marrow TransplantationEtoposideGraft SurvivalStem Cell NicheMultiple MyelomaAntineoplastic AgentsCell DifferentiationDoxorubicinNeural Stem CellsAntineoplastic Agents, AlkylatingDisease-Free SurvivalBusulfanInduced Pluripotent Stem CellsBlood CellsLymphoma, Non-HodgkinHematopoiesisStem Cell FactorBlood Cell CountCisplatinThiotepaSurvival RateMultipotent Stem CellsFetal BloodMesenchymal Stem Cell TransplantationSurvival AnalysisRecurrenceIfosfamideNeoplasmsMesenchymal Stromal CellsBreast NeoplasmsCell LineageCytarabineScienceSalvage TherapyTissue DonorsTime FactorsMyeloablative AgonistsWhole-Body IrradiationBone Marrow CellsHodgkin DiseaseCarboplatinRemission InductionLeukemiaTransplantation ChimeraColony-Forming Units AssayStem Cell ResearchMethotrexatePrognosisHistocompatibilityCell SeparationInfectionCells, CulturedLeukemia, Myeloid, AcuteBone MarrowDrug Administration ScheduleVidarabineFlow CytometryLymphomaFollow-Up StudiesPlatelet CountHistocompatibility TestingHematologic DiseasesBone Marrow PurgingPlant StemsRecombinant ProteinsCell ProliferationFetal Stem CellsNeoplasm StagingBlood DonorsNeutropeniaNeoadjuvant TherapyImmunomagnetic SeparationPOEMS SyndromeBone Marrow DiseasesResearch Personnel